Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Effect of vasodilator PGE1 on sciatic nerve function, VEGF level, vascular permeability and peripheral nerve in type 2 diabetic rats

Fang Wang¹, Yufang Liu² , Xiue Xu³, Yuan Chen⁴, Guiyan Chen⁵

¹Department of Nuclear Medicine; ²Department of Radiology, The Peopleâ€™s Hospital of Binzhou, Binzhou 256610; ³Department of 3M, Yangxin TCM Hospital of Shandong Province, Yangxin 251800; ⁴Department of Ophthalmology, Wudi Peopleâ€™s Hospital, Wudi 251900; ⁵Department of Endocrine, The Peopleâ€™s Hospital of Binzhou, Binzhou 256610, China.

For correspondence:- Yufang Liu Email: pcn32z@163.com

Accepted: 6 July 2019 Published: 28 July 2019

Citation: Wang F, Liu Y, Xu X, Chen Y, Chen G. Effect of vasodilator PGE1 on sciatic nerve function, VEGF level, vascular permeability and peripheral nerve in type 2 diabetic rats. Trop J Pharm Res 2019; 18(7):1481-1485 doi: 10.4314/tjpr.v18i7.17

© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect of vasodilator prostaglandin E1 (PGE1) on sciatic nerve function, vascular endothelial growth factor (VEGF), vascular permeability and peripheral nerve in type 2 diabetes mellitus (T2DM) rats.

Methods: Twenty-one rats in the study group were intraperitoneally injected with PGE1, while rats in T2DM untreated group (n = 21) were injected with an equivalent amount of normal saline. Seven rats were randomly selected from the study and the control groups every seven days for 21 days for determination of changes in sciatic nerve function, VEGF level, vascular permeability and peripheral nerves.

Results: Sciatic nerve motor nerve conduction velocity (MNCV) was significantly higher in the study group than in T2DM untreated control group at the three time-points post-treatment (p < 0.01). The level of VEGF in the study group decreased, relative to the T2DM untreated control group on the 7th 14th and 21st days post- treatment (p < 0.05) while the water content of sciatic nerve tissue in study group was markedly decreased, relative to control value on day 21 (p < 0.05). Rats in the study group showed decreased TTT, relative to those in T2DM untreated group on days 7, 14 and 21 post-treatment (p < 0.01).

Conclusion: PGE1 improves the sciatic nerve function of T2DM rats, reduces the level of serum VEGF and vascular permeability, and protects peripheral nerves. These findings provide a basis for the development of new T2DM drugs.

Keywords: Prostaglandin E1 (PGE1), Type 2 diabetes, Sciatic nerve function, VEGF, Vascular permeability, Peripheral nerve